{"id":5280,"date":"2015-12-31T21:36:14","date_gmt":"2015-12-31T21:36:14","guid":{"rendered":"http:\/\/www.marijuana.com\/?p=46025"},"modified":"2015-12-31T21:36:14","modified_gmt":"2015-12-31T21:36:14","slug":"cbd-research-dea-loosens-restrictions-for-studying-beneficial-cannabinoid","status":"publish","type":"post","link":"https:\/\/cannitrol.com\/blog\/cbd-research-dea-loosens-restrictions-for-studying-beneficial-cannabinoid\/","title":{"rendered":"CBD Research: DEA Loosens Restrictions for Studying Beneficial Cannabinoid"},"content":{"rendered":"<div id=\"wp_fb_like_button\" style=\"margin:5px 0 5px 5px;float:right;height:100px;\"><script src=\"http:\/\/connect.facebook.net\/en_US\/all.js#xfbml=1\"><\/script><fb:like href=\"https:\/\/cannitrol.com\/blog\/cbd-research-dea-loosens-restrictions-for-studying-beneficial-cannabinoid\/\" send=\"true\" layout=\"standard\" width=\"450\" show_faces=\"false\" font=\"arial\" action=\"like\" colorscheme=\"light\"><\/fb:like><\/div><p>Whether for greed or science, the DEA has reduced\u00a0restrictions on\u00a0\u00a0researching\u00a0the CBD\u00a0cannabinoid.<\/p>\n<p>Last week rumor, innuendo, and hope filled the air. As the charitable season of Christmas took hold, there was a glimmer of hope that the DEA (Drug Enforcement Administration) could be on the precipice of a historic decision, <a href=\"http:\/\/www.marijuana.com\/blog\/news\/2015\/12\/fda-issues-marijuana-rescheduling-recommendation-to-dea\/#%20FDA%20Issues%20Marijuana%20Rescheduling%20Recommendation%20to%20DEA\">downgrading the Schedule I status<\/a> of our favorite medicinal herb.<\/p>\n<p>While that didn\u2019t happen\u2026this did: The United States Drug Enforcement Administration moved to ease the odious constraints surrounding one of the plant\u2019s more beneficial non-psychoactive cannabinoids. Ultimately helping to reduce the research requirements for those who are piloting FDA-sanctioned trials on the CBD cannabinoid \u2013 a.k.a cannabidiol.<\/p>\n<p>This long-overdue adjustment will simplify and fast track the overall research process required by the FDA regarding <a href=\"http:\/\/www.marijuana.com\/?s=CBD++\" target=\"_blank\">CBD\u2019s potential medical value<\/a>. As a means of broadcasting this wonderful information to the affected scientific world, the DEA fired off a letter notifying the scientific community of these potent changes.<\/p>\n<p>Effective immediately:<\/p>\n<div id=\"attachment_46026\" style=\"width: 710px\" class=\"wp-caption aligncenter\"><img loading=\"lazy\" class=\"size-full wp-image-46026\" src=\"http:\/\/www.marijuana.com\/wp-content\/uploads\/2015\/12\/Screen-Shot-2015-12-31-at-11.02.03-AM.png?dc83c3\" alt=\"CBD Research: DEA Loosens Restrictions for Studying Beneficial Cannabinoid\" width=\"700\" height=\"193\" \/><\/p>\n<p class=\"wp-caption-text\">CBD Research: DEA Loosens Restrictions for Studying Beneficial Cannabinoid<\/p>\n<\/div>\n<p>The DEA notes that under <a href=\"http:\/\/www.dea.gov\/divisions\/hq\/2015\/hq122315.shtml#DEA%20Eases%20Requirements%20for%20FDA-Approved%20Clinical%20Trials%20on%20Cannabidiol\">these new changes<\/a>, \u201ca previously registered CBD clinical researcher who is granted a waiver can readily modify their protocol and continue their research seamlessly. This waiver effectively removes a step from the approval process.\u201d<\/p>\n<p>While this smells like great news at first whiff for the cannabis community, more than a few advocates of real medical marijuana are concerned this move is little more than a slap on the back by the good ol\u2019 boys in the federal government, signaling the moneygrubbing greed mongers of Big Pharma that it&#8217;s time to cash in on synthetic\u00a0CDB.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Whether for greed or science, the DEA has reduced\u00a0restrictions on\u00a0\u00a0researching\u00a0the CBD\u00a0cannabinoid. Last week rumor, innuendo, and hope filled the air. As the charitable season of Christmas took hold, there was a glimmer of hope that the DEA (Drug Enforcement Administration) could be on the precipice of a historic decision, downgrading the Schedule I status of [&#8230;] <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[2582,98,147,2421,2437,9,5015,1777,1,3],"tags":[2583,2676,2725,2427,2443,5016,4345],"_links":{"self":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/posts\/5280"}],"collection":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/comments?post=5280"}],"version-history":[{"count":0,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/posts\/5280\/revisions"}],"wp:attachment":[{"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/media?parent=5280"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/categories?post=5280"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cannitrol.com\/blog\/wp-json\/wp\/v2\/tags?post=5280"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}